Drug Type Small molecule drug |
Synonyms SEL-141, SLV-00095, SLV-00125 + [4] |
Target |
Action inhibitors |
Mechanism DYRK1A inhibitors(Dual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | Poland | - | |
Neoplasms | Discovery | Poland | - |